Literature DB >> 21999873

Cardiac magnetic resonance in hypertrophic cardiomyopathy.

Andrew C Y To1, Ashwat Dhillon, Milind Y Desai.   

Abstract

Hypertrophic cardiomyopathy is a complex genetic cardiovascular disorder with substantial variability in phenotypic expression and natural progression. Recent research demonstrates the incremental utility of cardiac magnetic resonance in the diagnosis, therapeutic planning, and prognostication of this disease. The increasing incorporation of multimodality imaging of hypertrophic cardiomyopathy in clinical practice will continue to improve our understanding of the subtle morphologic differences and their prognostic implications.
Copyright © 2011 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Year:  2011        PMID： 21999873     DOI： 10.1016/j.jcmg.2011.06.022

Source DB:  PubMed          Journal:  JACC Cardiovasc Imaging        ISSN： 1876-7591


  18 in total

Review 1.  Utility of late gadolinium enhancement in pediatric cardiac MRI.

Authors:  Maryam Etesami; Robert C Gilkeson; Prabhakar Rajiah
Journal:  Pediatr Radiol       Date:  2015-12-30

2.  Eccentric apical hypertrophic cardiomyopathy unmasked by multimodality imaging: an uncommon but missed cause of out of hospital cardiac arrest.

Authors:  Eric Towe; Saurabh Sharma; Jeffrey Geske; Michael J Ackerman
Journal:  BMJ Case Rep       Date:  2015-07-06

3.  Electrocardiographic Characterization of Cardiac Hypertrophy in Mice that Overexpress the ErbB2 Receptor Tyrosine Kinase.

Authors:  Polina Sysa-Shah; Lars L Sørensen; M Roselle Abraham; Kathleen L Gabrielson
Journal:  Comp Med       Date:  2015-08       Impact factor: 0.982

Review 4.  Sudden cardiac death in patients with nonischemic cardiomyopathy.

Authors:  Brian P Betensky; Sanjay Dixit
Journal:  Indian Heart J       Date:  2014-01-06

5.  The relationship between myocardial fibrosis detected by cardiac magnetic resonance and Tp-e interval, 5-year sudden cardiac death risk score in hypertrophic cardiomyopathy patients.

Authors:  Ali Riza Demir; Ömer Celik; Samet Sevinç; Begüm Uygur; Serkan Kahraman; Emre Yilmaz; Mete Cemek; Yilmaz Onal; Mehmet Erturk
Journal:  Ann Noninvasive Electrocardiol       Date:  2019-06-01       Impact factor: 1.468

6.  The Role of Cardiac MRI in the Diagnosis and Risk Stratification of Hypertrophic Cardiomyopathy.

Authors:  Ethan J Rowin; Martin S Maron
Journal:  Arrhythm Electrophysiol Rev       Date:  2016

Review 7.  Systolic anterior motion of the mitral valve in hypertrophic cardiomyopathy: a narrative review.

Authors:  Sarah A Guigui; Christian Torres; Esteban Escolar; Christos G Mihos
Journal:  J Thorac Dis       Date:  2022-06       Impact factor: 3.005

8.  The relationship between electrocardiographic changes and CMR features in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy.

Authors:  Xiuyu Chen; Tao Zhao; Minjie Lu; Gang Yin; Wei Xiangli; Shiliang Jiang; Sanjay Prasad; Shihua Zhao
Journal:  Int J Cardiovasc Imaging       Date:  2014-04-11       Impact factor: 2.357

9.  Altered regional cardiac wall mechanics are associated with differential cardiomyocyte calcium handling due to nebulette mutations in preclinical inherited dilated cardiomyopathy.

Authors:  K Maiellaro-Rafferty; J P Wansapura; U Mendsaikhan; H Osinska; J F James; M D Taylor; J Robbins; E G Kranias; J A Towbin; E Purevjav
Journal:  J Mol Cell Cardiol       Date:  2013-04-28       Impact factor: 5.000

10.  Impact of cardiovascular magnetic resonance on management and clinical decision-making in heart failure patients.

Authors:  Siddique A Abbasi; Andrew Ertel; Ravi V Shah; Vineet Dandekar; Jaehoon Chung; Geetha Bhat; Ankit A Desai; Raymond Y Kwong; Afshin Farzaneh-Far
Journal:  J Cardiovasc Magn Reson       Date:  2013-10-01       Impact factor: 5.364
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.